Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 Sep;55(1):51–56. doi: 10.1111/j.1476-5381.1975.tb07609.x

On the ability of prostaglandin E1, and arachidonic acid to modulate experimentally induced oedema in the rat paw.

A J Lewis, D J Nelson, M F Sugrue
PMCID: PMC1666721  PMID: 1182349

Abstract

1 Prostaglandins E1 and E2 but not prostaglandin F2alpha, arachidonic acid or linolenic acid, produced slight oedema when injected into the rat hindpaw. 2 Prostaglandin E1 potentiated hindpaw oedema produced by carrageenan, kaolin, bradykinin and trypsin but not that produced by 5-hydroxytryptamine (5-HT), histamine, dextran B or compound 48/80. Carrageenan- and bradykinin-induced paw oedemas were also potentiated by prostaglandin E2. Arachidonic acid potentiated responses to carrageenan and kaolin but not responses to bradykinin, trypsin, 5-HT, histamine, dextran B or compound 48/80. Linolenic acid did not potentiate hindpaw oedema induced by carrageenan. 3 Potentiation of carrageenan-induced oedema by prostaglandin E1 was not diminished by pretreatment with indomethacin, hydrocortisone or cyproheptadine. However, arachidonic acid potentiation of carrageenan oedema was reduced by pretreatment with non-steroidal anti-inflammatory drugs but not by anti-inflammatory steroids or by paracetamol. 4 The enhancement of the response to carrageenan and kaolin by prostaglandins E1, E2 and arachidonic acid is discussed in terms of kinin mediation.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora S., Lahiri P. K., Sanyal R. K. The role of prostaglandin E1 in inflammatory process in the rat. Int Arch Allergy Appl Immunol. 1970;39(2-3):186–191. doi: 10.1159/000230346. [DOI] [PubMed] [Google Scholar]
  2. BERGSTROEM S., DANIELSSON H., SAMUELSSON B. THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32. Biochim Biophys Acta. 1964 Jul 15;90:207–210. doi: 10.1016/0304-4165(64)90145-x. [DOI] [PubMed] [Google Scholar]
  3. Crunkhorn P., Meacock S. C. Mediators of the inflammation induced in the rat paw by carrageenin. Br J Pharmacol. 1971 Jul;42(3):392–402. doi: 10.1111/j.1476-5381.1971.tb07124.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crunkhorn P., Willis A. L. Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol. 1971 Jan;41(1):49–56. doi: 10.1111/j.1476-5381.1971.tb09934.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Di Rosa M. Biological properties of carrageenan. J Pharm Pharmacol. 1972 Feb;24(2):89–102. doi: 10.1111/j.2042-7158.1972.tb08940.x. [DOI] [PubMed] [Google Scholar]
  6. Di Rosa M., Willoughby D. A. Screens for anti-inflammatory drugs. J Pharm Pharmacol. 1971 Apr;23(4):297–298. doi: 10.1111/j.2042-7158.1971.tb08661.x. [DOI] [PubMed] [Google Scholar]
  7. Ferreira S. H., Moncada S., Parsons M., Vane J. R. Proceedings: the concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin. Br J Pharmacol. 1974 Sep;52(1):108P–109P. [PMC free article] [PubMed] [Google Scholar]
  8. Ferreira S. H., Moncada S., Vane J. R. Proceedings: Potentiation by prostaglandins of the nociceptive activity of bradykinin in the dog knee joint. Br J Pharmacol. 1974 Mar;50(3):461P–461P. [PMC free article] [PubMed] [Google Scholar]
  9. Ferreira S. H. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972 Dec 13;240(102):200–203. doi: 10.1038/newbio240200a0. [DOI] [PubMed] [Google Scholar]
  10. Flower R., Gryglewski R., Herbaczyńska-Cedro K., Vane J. R. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nat New Biol. 1972 Jul 26;238(82):104–106. doi: 10.1038/newbio238104a0. [DOI] [PubMed] [Google Scholar]
  11. Greaves M. W., McDonald-Gibson W. Prostaglandin biosynthesis by human skin and its inhibition by corticosteroids. Br J Pharmacol. 1972 Sep;46(1):172–175. doi: 10.1111/j.1476-5381.1972.tb06861.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Green A. Y., Green D., Murray P. A., Wilson A. B. Factors influencing the inhibitory action of anti-inflammatory drugs on carrageenin induced oedema. Br J Pharmacol. 1971 Jan;41(1):132–139. doi: 10.1111/j.1476-5381.1971.tb09943.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Higgs G. A., Youlten L. J. Proceedings: Prostaglandin production by rabbit peritoneal polymorphonuclear leukocytes in vitro. Br J Pharmacol. 1972 Feb;44(2):330P–330P. [PMC free article] [PubMed] [Google Scholar]
  14. JORI A., BENTIVOGLIO A. P., GARATTINI S. The mechanism of the local inflammatory reaction induced by compound 48/80 and dextran in rats. J Pharm Pharmacol. 1961 Oct;13:617–619. doi: 10.1111/j.2042-7158.1961.tb11878.x. [DOI] [PubMed] [Google Scholar]
  15. Kaley G., Weiner R. Prostaglandin E-1: a potential mediator of the inflammatory response. Ann N Y Acad Sci. 1971 Apr 30;180:338–350. doi: 10.1111/j.1749-6632.1971.tb53203.x. [DOI] [PubMed] [Google Scholar]
  16. Lewis A. J., Nelson D. J., Sugrue M. F. Proceedings: Potentiation by prostaglandin E1 and arachidonic acid of oedema in the rat paw induced by various phlogogenic agents. Br J Pharmacol. 1974 Mar;50(3):468P–469P. [PMC free article] [PubMed] [Google Scholar]
  17. Moncada S., Ferreira S. H., Vane J. R. Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature. 1973 Nov 23;246(5430):217–219. doi: 10.1038/246217a0. [DOI] [PubMed] [Google Scholar]
  18. Smith M. J., Ford-Hutchinson A. W., Elliott P. N., Bolam J. P. Prostaglandins and the anti-inflammatory activity of a human plasma fraction in carrageenan-induced paw oedema in the rat. J Pharm Pharmacol. 1974 Sep;26(9):692–698. doi: 10.1111/j.2042-7158.1974.tb09352.x. [DOI] [PubMed] [Google Scholar]
  19. Thomas G., West G. B. Prostaglandins, kinin and inflammation in the rat. Br J Pharmacol. 1974 Feb;50(2):231–235. doi: 10.1111/j.1476-5381.1974.tb08566.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Vargaftig B. B., Hai N. D. Inhibition by acetamidophenol of the production of prostaglandin-like material from blood platelets in vitro in relation to some in vivo actions. Eur J Pharmacol. 1973 Dec;24(3):283–288. doi: 10.1016/0014-2999(73)90151-9. [DOI] [PubMed] [Google Scholar]
  21. Williams T. J., Morley J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973 Nov 23;246(5430):215–217. doi: 10.1038/246215a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES